EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Serological Biomarkers for Autoimmune Hepatitis

Kazumichi Abe iD, Jun Wada, Hiromasa Ohira

Journal of Clinical Medicine · 01.07.2026 · 15 (13) · 5123

DOI: 10.3390/jcm15135123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.07.2026. Verfasst von Kazumichi Abe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Japan. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune hepatitis (AIH) lacks a disease-specific diagnostic biomarker, particularly for patients who present with acute onset, normal IgG levels, or seronegative profiles. Recent advances in high-throughput autoantibody profiling technologies have enabled the systematic discovery of novel AIH-associated autoantigens. This review summarizes emerging autoantibodies that have been identified through proteome-wide screening approaches, including human protein microarrays and phage immunoprecipitation sequencing. Particular attention is given to anti-docking protein 2 (DOK2) and anti-mitochondrial ribosomal protein S27 (MRPS27) antibodies, which have shown promising diagnostic performance. Importantly, the combined assessment of these autoantibodies markedly improves the diagnostic sensitivity for AIH and may be useful for screening or clinical triage, although its reduced specificity limits its use as a stand-alone confirmatory test. We also discuss how the integration of serological biomarkers with molecular pathology and spatial immune analysis may advance the understanding of AIH pathogenesis. These developments highlight the potential of proteome-wide autoantibody discovery to refine diagnostic strategies for AIH and provide new insights into disease mechanisms.

Schlagwörter

Stichwörter der Autor:innen

autoantibodyautoimmune hepatitisdocking protein 2human protein microarraymitochondrial ribosomal protein S27

Autor:innen und Institutionen

  • Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Japan.

ORCID-Profile: Kazumichi Abe

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Abe, K., Wada, J., & Ohira, H. (2026). Emerging Serological Biomarkers for Autoimmune Hepatitis. Journal of Clinical Medicine, 15(13), 5123. https://doi.org/10.3390/jcm15135123

Vancouver

Abe K, Wada J, Ohira H. Emerging Serological Biomarkers for Autoimmune Hepatitis. Journal of Clinical Medicine. 2026;15(13):5123. doi:10.3390/jcm15135123

BibTeX
@article{Abe2026,
  author = {Abe, Kazumichi and Wada, Jun and Ohira, Hiromasa},
  title = {Emerging Serological Biomarkers for Autoimmune Hepatitis},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {13},
  pages = {5123},
  doi = {10.3390/jcm15135123}
}
Kostenlos starten →